BR - Broadridge Financial Solutions, Inc. Pick

Research brief

Aug 24, 2026 Afternoon

05:20 PM UTC

Broadridge Financial Solutions, Inc. BR medium

Conf. Medium

Pick Pr. $185.45

Stop Pr. $174.01

Curr. Pr. $185.45

Change +0.00%

Rem. Days 28

Summary

Recommendation: Buy BR at the August 24 refreshed reference price of $184.90, using $174.00 as the hard stop and $202.00 as the five-week target; close any remainder at the September 28 liquid window. finance.yahoo
The catalyst is substantive and recent: Broadridge's August 4 release reported 8% recurring-revenue growth, 12% adjusted-EPS growth, $1.233 billion of free cash flow at 110% conversion, fiscal-2027 growth guidance, a 12% dividend increase, and a $1.5 billion repurchase authorization. broadridge-ir
The setup has a 9.25% target return versus 5.90% stop risk. The preserved scenario assumptions—43% target, 26% stop, and 31% time exit at +1.5%—produce an estimated +2.81% net five-week return after 0.10% friction. These probabilities and returns are analyst estimates, not guarantees. finance.yahoo
BR ranked ahead of all nine other reviewed finalists on refreshed modeled return; BSX was the closest alternative at +2.05%. Every finalist passed the safety gate, so the alternatives are opportunity-cost rejections rather than hard rejects. finance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahofinance.yaho
Confidence is Medium, not High, because the refreshed quote was modestly below session VWAP on light participation, technology tape was weak, and the expected return depends on clearing the nearer $190 resistance. finance.yahoofinance.yaho

Why Now

The August 4 results created a synchronized fundamental catalyst: recurring revenue and adjusted EPS grew, cash conversion exceeded 100%, management issued fiscal-2027 recurring-revenue growth guidance of 6%–8% and adjusted-EPS growth guidance of 8%–12%, and the board increased both dividend support and buyback capacity. broadridge-ir That combination is stronger for a five-week rerating case than a headline earnings beat alone because it supplies operating growth, cash realization, forward guidance, and capital-return support at the same time. Analyst interpretation: this breadth is the core edge.

Price action confirms that the market has retained much of the catalyst. At the final refresh, BR traded at $184.90, above the prior completed-session high of $182.52 and the $179.20 200-day average; over 20 completed sessions, it had outperformed XLK by 14.07 percentage points and SPY by 15.64 points. finance.yahoo The August 4 close rose 7.04%, and the event range was about 1.82 times pre-event ATR14, so the prescribed overextension gate did not activate. finance.yahoo

Entry quality is positive but imperfect. The quote was modestly below the approximately $185.40 session VWAP, and live participation was light relative to average volume; however, completed-bar acceptance above prior resistance remained intact. finance.yahoo The nearest obstacle is $190, while the preserved five-week target remains $202—the first resistance is a path diagnostic, not a substitute for the terminal target. finance.yahoo The 43% target probability preserves the decider's obstacle-conditioned assumption of roughly 68% odds of clearing $190 multiplied by 63% conditional odds of reaching $202. finance.yahoo

BR's +2.81% modeled net return exceeded BSX's +2.05%, COO's +1.94%, VRTX's +1.57%, ALB's +1.38%, and PSKY's +1.33%. finance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahoofinance.yahoo BSX, the best rejected finalist, had slower second-half growth guidance, competitive pressure in WATCHMAN and electrophysiology, and a below-VWAP quote; COO required an early exit before earnings; VRTX was close to its 52-week high; ALB faced commodity-conditioned supply; and PSKY carried materially greater leverage and legal-event risk. news.bostonsquartrfinance.yahoostocktwitsfinance.yahoofinance.yahooinvestors.alfinance.yahoosec.govstocktwits

Business And Market Context

The supplied evidence characterizes Broadridge as a financial-technology company with a recurring-revenue profile. finance.yaho The detailed product and segment mix was not included in the supplied research, so this report does not make unsupported claims about individual business lines or market share. For this trade, the relevant business feature is the demonstrated recurring-revenue growth and its conversion into adjusted earnings and free cash flow. broadridge-ir

The broad tape supports selective risk-taking rather than indiscriminate beta. SPY was about 8.0% above its 200-day average, while QQQ and XLK were below their 50-day averages; the evidence therefore described the regime as rotation rather than a crash. finance.yahofinance.yahofinance.yaho Supplied portfolio context (uncited): Technology was also a relatively heavy allocation at about 18.7%, so BR needed a superior stock-specific catalyst and return profile to justify additional sector exposure. It met that standard through strong relative performance and the highest refreshed modeled return in the finalist set. finance.yahoo

The supplied evidence identified no decision-critical company-specific binary event before the next executable stop window. It also found adequate liquidity, strong free-cash-flow conversion, a feasible structural stop, and remaining five-week upside. broadridge-irfinance.yahoo Macro and technology-sector volatility can still affect the path, but the evidence does not support treating the market as a bear or crash regime. finance.yahofinance.yahofinance.yaho

Factor Stack

Factor	Assessment
Catalyst/news edge	Strong. The August 4 release joined recurring-revenue growth, adjusted-EPS growth, fiscal-2027 guidance, 110% free-cash-flow conversion, a dividend increase, and repurchase authorization. broadridge-ir
Growth and profitability	Positive. Recurring revenue grew 8%, adjusted EPS grew 12%, and free cash flow was $1.233 billion. broadridge-ir
Financial health	Adequate, with leverage to monitor. Long-term debt rose to $3.255 billion and cash declined to $403 million, but there was no current portion of long-term debt and free-cash-flow conversion remained strong. broadridge-ir
Valuation	Unresolved/neutral. The supplied BR evidence includes a $21.08 billion market capitalization and a $133.83–$263.00 52-week range, but no current earnings multiple or peer-comparison set; no valuation uplift is assumed. finance.yahoo
Momentum and relative strength	Strong but not pristine intraday. BR was above its prior completed-session high and 200-day average and materially outperformed SPY and XLK over 20 sessions, but sat modestly below session VWAP on light participation. finance.yahoo
Sentiment/social confirmation	Unavailable; no uplift. Evidence limitation (uncited): The supplied outputs do not provide a reliable, citable BR-specific social signal.
EPS revisions/estimate direction	Guidance-positive, revisions unverified. Management guided to 8%–12% fiscal-2027 adjusted-EPS growth. broadridge-ir Evidence limitation (uncited): The supplied outputs contain no independent analyst-revision series, so the thesis receives credit for issuer guidance only.
Entry geometry	Favorable with a visible hurdle. The $174 stop is about 1.66 ATR below entry, $190 is first resistance, and $202 is the five-week target. finance.yahoo

Investment Thesis

BR is the best immediate five-week pick because the fundamental and technical evidence points in the same direction. The issuer's August 4 update showed growth in recurring revenue and adjusted EPS, strong free-cash-flow conversion, constructive fiscal-2027 guidance, and enhanced capital returns. broadridge-ir The market then accepted the repricing above prior completed-session resistance and the 200-day average, while BR generated substantial 20-session relative strength against both SPY and XLK. finance.yahoo

The risk plan is also executable at the reference quote. From $184.90, the $174.00 stop represents a 5.90% loss, while $202.00 represents 9.25% upside and a raw reward/risk ratio of about 1.57x. finance.yahoo Analyst estimate: applying the preserved 43%/26%/31% scenario mix, +1.5% time-exit return, and 0.10% friction yields +2.81% expected net return, or approximately +0.48R. finance.yahoo

The thesis does not require the stock to jump directly to $202. It requires BR first to work through $190, with the catalyst remaining credible and the breakout structure holding. finance.yahoo Analyst interpretation: recurring growth and capital-return support give the stock a plausible reason to consolidate constructively and then extend, while the fixed stop prevents a failed breakout from becoming an open-ended hold.

Risks And Thesis Breakers

Breakout failure: A close below the relevant 200-day area followed by failure to reclaim it would weaken the technical thesis; regardless, $174.00 remains the authoritative stop. finance.yahoo
Resistance and participation: BR was below the approximately $185.40 session VWAP on light participation, and $190 is the first obstacle. Failure to clear $190 with improving acceptance would reduce the probability of reaching $202. finance.yahoo
Fundamental deceleration: The thesis would weaken materially if recurring-revenue growth or adjusted-EPS growth fell below the fiscal-2027 ranges supplied on August 4, or if free-cash-flow conversion deteriorated enough to undermine capital returns. The stated guidance ranges were 6%–8% and 8%–12%, respectively. broadridge-ir
Leverage and liquidity: Long-term debt increased to $3.255 billion while cash declined to $403 million. Strong free-cash-flow conversion prevented this from becoming a solvency gate, but further debt growth paired with weaker cash conversion would break an important support for the thesis. broadridge-ir
Sector and macro risk: QQQ and XLK were below their 50-day averages, so renewed technology de-risking could overwhelm BR's relative strength. finance.yahofinance.yaho Supplied portfolio context (uncited): The position also adds to an already heavy technology allocation.
Evidence limitations (uncited): No reliable BR-specific social signal, independent EPS-revision series, or current valuation-comparison set was supplied. Those factors receive no positive weight, limiting confidence to Medium.

Investment Recommendation

Buy BR now using $184.90 as the decision reference price, $174.00 as the hard stop, $190.00 as the first resistance checkpoint, and $202.00 as the unchanged five-week target. finance.yahoo The scenario plan preserves a 43% target probability, 26% stop probability, and 31% time-exit probability with a +1.5% time-exit return; these are analyst assumptions and sum to 100%. finance.yahoo

Do not move the stop lower to accommodate volatility. If $202 is reached early—or the position first gains roughly 5%–8%—protect the gain with a trim or a breakeven/tighter trailing stop. Exit any remaining position at the September 28 liquid window if neither terminal price has been reached. finance.yahoo

The recommendation is Medium confidence: BR offers the strongest synchronized catalyst, relative strength, stop feasibility, and modeled expected return among the reviewed finalists, but below-VWAP participation, weak technology tape, leverage, and incomplete sentiment/valuation evidence prevent a High rating. broadridge-irfinance.yahoofinance.yaho